Mengxuan Wang
210095, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
GPAT3 is associated with lipid deposition and AMPK signaling in skeletal muscle.
Journal: Biochemical and biophysical research communications
Published: March 02, 2026
Synthesis of novel deuterated EGFR/ALK dual-target inhibitors and their activity against non-small cell lung cancer.
Journal: European journal of medicinal chemistry
Published: October 09, 2024
The new N2, N4-diphenylpyridine-2,4-diamine deuterated derivatives as EGFR inhibitors to overcome C797S-mediated resistance.
Journal: Bioorganic chemistry
Published: February 04, 2024
GPAT3 deficiency attenuates corticosterone-caused hepatic steatosis and oxidative stress through GSK3β/Nrf2 signals.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 23, 2023
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation.
Journal: Cell death & disease
Published: April 19, 2023
Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancer.
Journal: Bioorganic chemistry
Published: January 11, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026